Combination Therapy Can Prove Effective With Ovarian Cancer Patients As More Women File Talcum Powder Lawsuit Claims

November 28, 2016 – – TheProductLawyers.com reports on a release from EurekAlert concerning the use of combination therapy in patients with ovarian cancer.

According to the release, “Researchers at The Wistar Institute have shown that a class of drugs called bromodomain and extraterminal domain (BET) inhibitors can be used in combination with cisplatin to reduce a tumor’s resistance to chemotherapy.” This new research indicates that the effectiveness of the therapy could improve long-term survival rates.

This is good news for those suffering with ovarian cancer, especially now that many women have come forward saying that common household products such as Johnson & Johnson’s baby powder are linked to the disease. Over the last 45 years, numerous studies have found that women who use baby powder as a feminine hygiene product are more likely to develop ovarian cancer. These powders have been the subject of thousands of lawsuits filed by plaintiffs claiming that they have suffered from ovarian cancer as a result of its use. Johnson & Johnson has maintained denial in these claims and has previously stated that there is no link between talcum powder and ovarian cancer. The company has never released a warning about the potential risks of its Johnson’s Baby Powder and Shower To Shower products.

Several plaintiffs have already been awarded millions of dollars in compensation and lawsuit numbers are continuing to grow. Most of the filed cases are pending in a Missouri federal court, while others have been filed in New Jersey, where Johnson & Johnson is headquartered.

Banville Law has many years of experience fighting large pharmaceutical companies who have put dangerous drugs and devices onto the market, foregoing public safety for corporate greed.

The firm is looking to assist those who believe they have been directly affected by the use of Johnson’s talcum powder. Affected individuals may be entitled to financial compensation and legal action. Banville Law is currently offering free consultations to individuals who qualify.

For more information, to schedule a consultation or to ask questions contact Banville Law at (888) 976-6742.

###

Contact TheProductLawyers.com:

Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60013514